Regulatory
ViiV Healthcare’s Tivicay (dolutegravir, dispersible tablets) Receives the EMA’s Approval
Shots: The approval is based on P1093 & ODYSSEY (Penta20) studies assessing safety, tolerability & dose-finding of Tivicay (5mg) in pediatric patients aged 4wks.-18yrs. while the second study assessed the […]readmore